Oragenics (OGEN) Other Operating Expenses (2015 - 2022)

Oragenics' (OGEN) quarterly Other Operating Expenses came in at $490.0 in Q2 2022, up 100.01% on a QoQ basis from -$9.1 million in Q4 2020.

Oragenics (OGEN) Other Operating Expenses (2015 - 2022) Analysis & Trends

Oragenics (OGEN) has 4 years of Other Operating Expenses data on file, last reported at $490.0 in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn
10	Oragenics	2.38 Mn	2.38 Mn	-

Download Data